4processed
Form 4 — Insider Transaction
Maze Therapeutics, Inc.(MAZE)
Filing Date
June 1, 2026
Accepted
June 1, 2026
Accession No.
0002050172-26-000023
CIK
0001842295
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Bernstein Harold | President, R&D & CMO | Other | 14.9K | $10.42 | — | 14.9K | Common Stock | Jun 1, 2026 |
| Bernstein Harold | President, R&D & CMO | Other | 13.3K | $25.575 | — | 1.6K | Common Stock | Jun 1, 2026 |
| Bernstein Harold | President, R&D & CMO | Other | 1.6K | $26.358 | — | 0 | Common Stock | Jun 1, 2026 |
| Bernstein Harold | President, R&D & CMO | Other | 14.9K | $0 | — | 207.6K | Stock Option (Right to Buy) | Jun 1, 2026 |